Background: Clinical development of vaginally applied products aimed at reducing the transmission of HIV and other sexually transmitted infections, has highlighted the need for a better characterisation of the vaginal environment. We set out to characterise the vaginal environment in women in different settings in sub-Saharan Africa. Methods: A longitudinal study was conducted in Kenya, Rwanda and South-Africa. Women were recruited into pre-defined study groups including adult, non-pregnant, HIV-negative women; pregnant women; adolescent girls; HIV-negative women engaging in vaginal practices; female sex workers; and HIV-positive women. Consenting women were interviewed and underwent a pelvic exam. Samples of vaginal fluid and a blood sampl...
Background: Increasingly, research is being conducted to define the characteristics of a normal heal...
Background: Bacterial vaginosis (BV) is a dysbiosis of the healthy lactobacilli-dominated vaginal mi...
Background: The ideal microbicide should reduce the risk of HIV-infection while preserving the integ...
BACKGROUND:Clinical development of vaginally applied products aimed at reducing the transmission of ...
Clinical development of vaginally applied products aimed at reducing the transmission of HIV and oth...
Clinical development of vaginally applied products aimed at reducing the transmission of HIV and oth...
Background: Clinical development of vaginally applied products aimed at reducing the transmission of...
Copyright © 2013 J. Nzomo et al. This is an open access article distributed under the Creative Commo...
BACKGROUND:Estimates of sexually transmitted infection (STI) prevalence are essential for efforts to...
Background: Estimates of sexually transmitted infection (STI) prevalence are essential for efforts t...
<div><p>Background</p><p>Estimates of sexually transmitted infection (STI) prevalence are essential ...
Data on immune mediators in the genital tract and the factors that modulate them in sub-Saharan wome...
Background: Bacterial vaginosis (BV) is a polymicrobial, superficial vaginal infection involving a r...
This is a prospective study of 297 Consecutive High Vaginal Swab (HVS) specimen from patients with v...
Includes abstract.Includes bibliographical references (leaves 55-60).Bacterial vaginosis (BV) is a c...
Background: Increasingly, research is being conducted to define the characteristics of a normal heal...
Background: Bacterial vaginosis (BV) is a dysbiosis of the healthy lactobacilli-dominated vaginal mi...
Background: The ideal microbicide should reduce the risk of HIV-infection while preserving the integ...
BACKGROUND:Clinical development of vaginally applied products aimed at reducing the transmission of ...
Clinical development of vaginally applied products aimed at reducing the transmission of HIV and oth...
Clinical development of vaginally applied products aimed at reducing the transmission of HIV and oth...
Background: Clinical development of vaginally applied products aimed at reducing the transmission of...
Copyright © 2013 J. Nzomo et al. This is an open access article distributed under the Creative Commo...
BACKGROUND:Estimates of sexually transmitted infection (STI) prevalence are essential for efforts to...
Background: Estimates of sexually transmitted infection (STI) prevalence are essential for efforts t...
<div><p>Background</p><p>Estimates of sexually transmitted infection (STI) prevalence are essential ...
Data on immune mediators in the genital tract and the factors that modulate them in sub-Saharan wome...
Background: Bacterial vaginosis (BV) is a polymicrobial, superficial vaginal infection involving a r...
This is a prospective study of 297 Consecutive High Vaginal Swab (HVS) specimen from patients with v...
Includes abstract.Includes bibliographical references (leaves 55-60).Bacterial vaginosis (BV) is a c...
Background: Increasingly, research is being conducted to define the characteristics of a normal heal...
Background: Bacterial vaginosis (BV) is a dysbiosis of the healthy lactobacilli-dominated vaginal mi...
Background: The ideal microbicide should reduce the risk of HIV-infection while preserving the integ...